Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124450882 | 12445088 | 2 | F | 20120222 | 20120713 | 20160607 | 20160822 | EXP | US-VALIDUS PHARMACEUTICALS LLC-US-2012VAL000708 | VALIDUS | 0.00 | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124450882 | 12445088 | 1 | PS | CALCITRIOL. | CALCITRIOL | 1 | Oral | 0.25 ?G, 1 IN 1 D | U | 18044 | .25 | UG | |||||||
| 124450882 | 12445088 | 2 | SS | NUTROPIN AQ | SOMATROPIN | 1 | Subcutaneous | 1.6 MG, 1 IN 1 IN 1 D | U | 0 | 1.6 | MG | SOLUTION FOR INJECTION | ||||||
| 124450882 | 12445088 | 3 | SS | NUTROPIN AQ | SOMATROPIN | 1 | Subcutaneous | 1.4 MG, 7 IN 1 WK | U | 0 | 1.4 | MG | SOLUTION FOR INJECTION | ||||||
| 124450882 | 12445088 | 4 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 325 MG, 1 IN 6 HOURS | U | 0 | 325 | MG | TABLET | ||||||
| 124450882 | 12445088 | 5 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 25 MG, 1 IN 6 HOURS | U | 0 | 25 | MG | TABLET | ||||||
| 124450882 | 12445088 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 325 MG, 1 IN 1 D | U | 0 | 325 | MG | ||||||||
| 124450882 | 12445088 | 7 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Oral | 325 MG, QD | U | 0 | 325 | MG | |||||||
| 124450882 | 12445088 | 8 | C | LASIX | FUROSEMIDE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | |||||||
| 124450882 | 12445088 | 9 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, UNK | U | 0 | 10 | MG | |||||||
| 124450882 | 12445088 | 10 | C | FISH OIL | FISH OIL | 1 | Oral | 1000 MG, QD | U | 0 | 1000 | MG | |||||||
| 124450882 | 12445088 | 11 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 150 MG, BID | U | 0 | 150 | MG | |||||||
| 124450882 | 12445088 | 12 | C | SOLIRIS | ECULIZUMAB | 1 | UNK | U | 0 | ||||||||||
| 124450882 | 12445088 | 13 | C | ZOSYN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124450882 | 12445088 | 1 | Product used for unknown indication |
| 124450882 | 12445088 | 2 | Chronic kidney disease |
| 124450882 | 12445088 | 4 | Product used for unknown indication |
| 124450882 | 12445088 | 5 | Product used for unknown indication |
| 124450882 | 12445088 | 6 | Product used for unknown indication |
| 124450882 | 12445088 | 7 | Metabolic acidosis |
| 124450882 | 12445088 | 8 | Hypertension |
| 124450882 | 12445088 | 9 | Allergy prophylaxis |
| 124450882 | 12445088 | 10 | Product used for unknown indication |
| 124450882 | 12445088 | 11 | Hyperuricaemia |
| 124450882 | 12445088 | 12 | Product used for unknown indication |
| 124450882 | 12445088 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124450882 | 12445088 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124450882 | 12445088 | Eosinophil count increased | |
| 124450882 | 12445088 | Haemolytic uraemic syndrome | |
| 124450882 | 12445088 | Influenza | |
| 124450882 | 12445088 | Malaise | |
| 124450882 | 12445088 | Pyrexia | |
| 124450882 | 12445088 | Rash maculo-papular | |
| 124450882 | 12445088 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124450882 | 12445088 | 3 | 20110603 | 0 |